🇺🇸 UTHR — United Therapeutics Corporation
Salud CompraPrecio actual
608,49 USD
Máx. histórico
608,49
0 días
Split 2:1 del 23/09/2009
Caída desde máximo
En máximo
Rango 52 semanas
432,53 – 614,23
Variación hoy
+1,19%
Cierre anterior
601,32
Rango de hoy
578,28 – 614,23
Volumen hoy
908.530
Peor caída histórica
-93,18%
12/07/2000 → 10/12/2001
Recuperado en 3311 días
Volatilidad anualizada ⓘ
46,95%
- Nombre completo
- United Therapeutics Corporation
- Divisa
- USD
- Mercado
- NasdaqGS
- Sector
- Salud
- Industria
- Drug Manufacturers - Specialty & Generic
- Empleados
- 1.400
- PER ⓘ
- 21,57 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 670,93 USD (puede no estar actualizado)
- Primera cotización
- 17/06/1999
- Precio actualizado
- hace 16 horas
United Therapeutics Corporation engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. It offers Tyvaso DPI, an inhaled dry powder via pre-filled and single-use cartridges; Nebulized Tyvaso, an inhaled solution via ultrasonic nebulizer; Remodulin (treprostinil) injection to treat patients with pulmonary arterial hypertension to diminish symptoms associated with exercise; Orenitram, a tablet dosage form of treprostinil, to delay disease progression and improve exercise capacity in PAH patients; and Adcirca, an oral PDE-5 inhibitor to enhance the exercise ability in PAH patients. It also markets and sells Unituxin (dinutuximab) injection, a monoclonal antibody for high-risk neuroblastoma; and Remunity Pump, which contains a pump and separate controller for Remodulin. In addition, it is involved in developing RemunityPRO Pump and Ralinepag for the treatment of PAH;and Nebulized Tyvaso, for the treatment of idiopathic pulmonary fibrosis, as well as xenografts, which are development-stage organ products. Further, it provides preclinical products, including EVLP/CLES, for lung transplant; UKidney, UHeart, UThymoKidney, a development-stage gene-edited porcine kidneys and hearts for xenotransplantation; ULobe, for allogeneic regenerative medicine; ULung, for autologous regenerative medicine; IVIVA Kidney, for autologous regenerative medicine; miroliver, for allogeneic regenerative medicine; and mirokidney, for allogeneic regenerative medicine. It has licensing and collaboration agreements with DEKA Research & Development Corp. to develop a semi-disposable system for the subcutaneous delivery of treprostinil; MannKind Corporation to develop and license treprostinil inhalation powder and the Dreamboat device; and Arena Pharmaceuticals, Inc. to develop Ralinepag. The company was founded in 1996 and is headquartered in Silver Spring, Maryland.
| Fecha | Ratio |
|---|---|
| 23/09/2009 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 26/05/2020 | 119,44 | 121,35 | 117,66 | 118,45 | +0,75% | 3,09% | 737.600 |
| 22/05/2020 | 117,33 | 117,98 | 116,32 | 117,57 | +0,32% | 1,41% | 679.700 |
| 21/05/2020 | 119,92 | 119,92 | 116,80 | 117,20 | -2,48% | 2,60% | 817.300 |
| 20/05/2020 | 120,24 | 121,00 | 118,62 | 120,18 | +1,47% | 1,98% | 654.400 |
| 19/05/2020 | 120,58 | 124,78 | 118,43 | 118,44 | -0,69% | 5,27% | 923.500 |
| 18/05/2020 | 118,24 | 119,78 | 117,42 | 119,26 | +2,49% | 2,00% | 1.045.400 |
| 15/05/2020 | 113,42 | 117,00 | 112,53 | 116,36 | +2,58% | 3,94% | 686.100 |
| 14/05/2020 | 112,10 | 114,14 | 111,34 | 113,43 | +0,31% | 2,50% | 388.800 |
| 13/05/2020 | 114,01 | 116,74 | 112,09 | 113,08 | -1,02% | 4,08% | 355.400 |
| 12/05/2020 | 117,66 | 118,90 | 114,15 | 114,25 | -1,22% | 4,04% | 600.400 |
| 11/05/2020 | 112,69 | 116,32 | 112,69 | 115,66 | +1,97% | 3,22% | 1.028.000 |
| 08/05/2020 | 114,00 | 114,57 | 112,71 | 113,43 | +1,29% | 1,63% | 310.500 |
| 07/05/2020 | 114,79 | 114,79 | 111,84 | 111,98 | -0,87% | 2,57% | 764.700 |
| 06/05/2020 | 113,27 | 115,39 | 112,31 | 112,96 | +1,25% | 2,72% | 386.300 |
| 05/05/2020 | 114,96 | 116,12 | 110,75 | 111,56 | -0,31% | 4,67% | 490.300 |
| 04/05/2020 | 108,88 | 111,92 | 107,42 | 111,91 | +2,56% | 4,13% | 901.500 |
| 01/05/2020 | 108,00 | 110,13 | 106,89 | 109,12 | -0,40% | 3,00% | 477.400 |
| 30/04/2020 | 108,18 | 112,09 | 105,87 | 109,56 | +1,47% | 5,75% | 1.345.500 |
| 29/04/2020 | 107,84 | 113,48 | 104,66 | 107,97 | -1,61% | 8,18% | 760.700 |
| 28/04/2020 | 112,79 | 113,45 | 109,38 | 109,74 | -1,65% | 3,61% | 632.500 |
| 27/04/2020 | 111,91 | 112,78 | 111,05 | 111,58 | +0,33% | 1,55% | 474.800 |
| 24/04/2020 | 110,82 | 111,98 | 107,40 | 111,21 | +1,11% | 4,13% | 1.272.200 |
| 23/04/2020 | 108,92 | 110,97 | 106,61 | 109,99 | +1,78% | 4,00% | 380.400 |
| 22/04/2020 | 105,97 | 109,43 | 105,22 | 108,07 | +3,91% | 3,97% | 603.800 |
| 21/04/2020 | 105,02 | 106,10 | 103,26 | 104,00 | -2,29% | 2,70% | 578.300 |
| 20/04/2020 | 104,08 | 108,68 | 103,05 | 106,44 | +1,74% | 5,41% | 624.200 |
| 17/04/2020 | 99,42 | 105,30 | 97,96 | 104,62 | +7,56% | 7,38% | 784.200 |
| 16/04/2020 | 98,69 | 98,69 | 94,26 | 97,27 | -0,14% | 4,49% | 608.300 |
| 15/04/2020 | 97,05 | 98,93 | 95,08 | 97,41 | -1,62% | 3,97% | 410.900 |
| 14/04/2020 | 99,00 | 99,98 | 97,85 | 99,01 | +0,77% | 2,15% | 589.700 |